Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emilio Portaccio

Showing results (61-70 of 151) with videos related to

Pageof 16
Sort By:
Journal of the Neurological Sciences|April 25, 2006
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairmentEmilio Portaccio, Maria Pia Amato, Maria Letizia Bartolozzi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 24, 2015
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosisNicola De Stefano, Maria Laura Stromillo, Antonio Giorgio, et al.
The Lancet Regional Health. Europe|October 24, 2024
Multiple sclerosis: emerging epidemiological trends and redefining the clinical courseEmilio Portaccio, Melinda Magyari, Eva Kubala Havrdova, et al.
Brain Sciences|November 27, 2021
Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and PrognosisMattia Fonderico, Emilio Portaccio, Lorenzo Razzolini, et al.
Plos One|May 5, 2012
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational studyPietro Iaffaldano, Rosa Gemma Viterbo, Damiano Paolicelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 8, 2024
Meaningful cognitive change for the Minimal Assessment of Cognitive Function in Multiple SclerosisEmilio Portaccio, Paola Grossi, Fabio Bellomi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 8, 2021
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical courseRosa Cortese, Marco Battaglini, Francesca Parodi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2020
Gray matter atrophy cannot be fully explained by white matter damage in patients with MSJian Zhang, Antonio Giorgio, Claudia Vinciguerra, et al.
Frontiers in Neurology|November 30, 2017
Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical DisabilityAntonio Giorgio, Jian Zhang, Maria Laura Stromillo, et al.
Annals of Neurology|April 21, 2007
New natural history of interferon-beta-treated relapsing multiple sclerosisMaria Trojano, Fabio Pellegrini, Aurora Fuiani, et al.
Pageof 16

Showing results (61-70 of 151) with videos related to

Sort By:
Pageof 16
Journal of the Neurological Sciences|April 25, 2006
Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairmentEmilio Portaccio, Maria Pia Amato, Maria Letizia Bartolozzi, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 24, 2015
Establishing pathological cut-offs of brain atrophy rates in multiple sclerosisNicola De Stefano, Maria Laura Stromillo, Antonio Giorgio, et al.
The Lancet Regional Health. Europe|October 24, 2024
Multiple sclerosis: emerging epidemiological trends and redefining the clinical courseEmilio Portaccio, Melinda Magyari, Eva Kubala Havrdova, et al.
Brain Sciences|November 27, 2021
Cerebrospinal Fluid IgM and Oligoclonal IgG Bands in Multiple Sclerosis: A Meta-Analysis of Prevalence and PrognosisMattia Fonderico, Emilio Portaccio, Lorenzo Razzolini, et al.
Plos One|May 5, 2012
Impact of natalizumab on cognitive performances and fatigue in relapsing multiple sclerosis: a prospective, open-label, two years observational studyPietro Iaffaldano, Rosa Gemma Viterbo, Damiano Paolicelli, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 8, 2024
Meaningful cognitive change for the Minimal Assessment of Cognitive Function in Multiple SclerosisEmilio Portaccio, Paola Grossi, Fabio Bellomi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 8, 2021
Mild gray matter atrophy in patients with long-standing multiple sclerosis and favorable clinical courseRosa Cortese, Marco Battaglini, Francesca Parodi, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 25, 2020
Gray matter atrophy cannot be fully explained by white matter damage in patients with MSJian Zhang, Antonio Giorgio, Claudia Vinciguerra, et al.
Frontiers in Neurology|November 30, 2017
Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical DisabilityAntonio Giorgio, Jian Zhang, Maria Laura Stromillo, et al.
Annals of Neurology|April 21, 2007
New natural history of interferon-beta-treated relapsing multiple sclerosisMaria Trojano, Fabio Pellegrini, Aurora Fuiani, et al.
Pageof 16